Editas Medicine, Inc. revenue breakdown overview

Editas Medicine, Inc. revenue for the last year amounted to 78.12 M USD, the most of which — 78.12 M USD — came from its highest performing source at the moment, Genome Editing Technology, the year earlier bringing 19.71 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Editas Medicine, Inc. 78.12 M USD, and the year before that — 19.71 M USD.